Letter to the Editor
Stem cell therapy for Parkinson's disease
First published: 24 February 2012
No abstract is available for this article.
References
- 1
Lunn JS,
Sakowski SA,
Hur J, et al.
Stem cell technology for neurodegenerative diseases.
Ann Neurol
2011;
70:
353–361.
- 2
Lang AE,
Obeso JA.
Current challenges in Parkinson's disease: restoring the nigrostriatal dopamine system will not suffice.
Lancet Neurol
2004;
3:
309–316.
- 3
Lang AE,
Obeso JA.
Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease.
Ann Neurol
2004;
55:
761–765.
- 4
Olanow CW,
Kordower JH,
Lang AE, et al.
Dopaminergic transplantation for Parkinson's disease: current status and future prospects.
Ann Neurol
2009;
66:
591–596.
- 5
Ahlskog JE.
Beating a dead horse—dopamine and Parkinson disease.
Neurology
2007;
69:
1701–1711.
